| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Forbion Growth Opportunities Fund III Cooperatief U.A. serves as a 10% Owner at BRVE. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $257.9M at current prices.
The biggest single holding is BRVE (~$257.9M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 3,600,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. Common Stock | 10% Owner | Buy | 3,600,000 | $18.00 | $64,800,000.00 | +19.8% |